Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672971 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
A NA study of Head Lice, sponsored by Oystershell.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT00672971: Completed NA study of Head Lice, sponsored by Oystershell.
NCT00672971 is a NA study of Head Lice that has completed, run by Oystershell. The registered enrollment target is 31 participants, below the 111-participant average among 5 other Head Lice trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672971, a NA study of Head Lice, has completed, sponsored by Oystershell.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to evaluate the efficacy of a dimethicone foam in the control of head lice and to compare the efficacy to a permethrin based product.
Conditions Studied
Interventions
- OTHER 4% dimethicone foam
- OTHER 1% permethrin
Study Locations (1)
Florida
- Lice Source Services Inc - Plantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00672971 record still lists
NCT00672971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 111-participant average among 5 other Head Lice trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which 4% dimethicone foam is the first listed.
NCT00672971 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00672971 about?
NCT00672971 is a clinical study titled "Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice". The purpose of this study was to evaluate the efficacy of a dimethicone foam in the control of head lice and to compare the efficacy to a permethrin based product.
What is the current status of trial NCT00672971?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2007-09. Estimated completion is 2007-11.
What conditions does trial NCT00672971 study?
This clinical trial studies the following conditions: Head Lice.
What interventions are being tested in trial NCT00672971?
The interventions under investigation include: 4% dimethicone foam (OTHER), 1% permethrin (OTHER).
Who is sponsoring clinical trial NCT00672971?
This trial is sponsored by Oystershell, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00672971 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Lice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
RECRUITING · NA
-
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
COMPLETED · NA
-
Pediatric Head Lice Study Product Comparison
COMPLETED · Phase 2
-
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
COMPLETED · Phase 2
-
A Pilot Dose Ranging Study of Spinosad Creme Rinse
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia